Search

Search Constraints

You searched for: Issue Volume 115(2018)

Search Results

60. A phase I trial of afatinib and bevacizumab in chemo-naïve patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 1404. (January 2018)